Trials / Completed
CompletedNCT02202720
Evaluation of Richmond Agitation Sedation Scale According to Alveolar Concentration of Sevoflurane During a Sedation With Sevoflurane in ICU Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Describe the Richmond Agitation Sedation Scale (RASS) values corresponding to the values of Minimum alveolar concentration of sevoflurane during sedation of patients in ICU
Detailed description
Prospective clinical study in ICU with sedated ventilated patients with sevoflurane using the Mirus® system. Pharmacological study of the concentration-effect relationship by administration at increasing and decreasing concentrations.
Conditions
- Requiring Sedation by Sevoflurane in ICU
- Adult Patients
- Patients Covered by French Health Care System
- Patients Who Have Given Their Consent
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sevoflurane | Short term sedation with sevoflurane in ICU |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2014-07-29
- Last updated
- 2014-11-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02202720. Inclusion in this directory is not an endorsement.